Data presented at the European Symposium on Ultrasound Contrast Imaging also demonstrated consistent SonoTran® Particle activationRecruitment underway for Delivery and Efficacy cohorts of Phase 1/2a proof of concept studyOXFORD, UK, January 23, 2023 / B3C newswire / OxSonics Therapeutics, a clinical-stage medtech.